Generali Asset Management SPA SGR Acquires New Shares in Amrize Ltd $AMRZ

Key Points

• Generali Asset Management SPA SGR acquired 99,353 shares of Amrize Ltd, valued at approximately $4.9 million, during the second quarter of the year.
• Insider transactions showed significant investments, with a total of 1,124,000 shares purchased by insiders in the past three months, indicating strong insider confidence in the company.
• Amrize recently reported earnings per share of $0.78, missing analysts' estimates, while several analysts issued price target revisions, with JPMorgan raising its target from $52.00 to $60.00.

Generali Asset Management SPA SGR acquired a new stake in shares of Amrize Ltd (NYSE:AMRZ - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 99,353 shares of the company's stock, valued at approximately $4,923,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Credit Industriel ET Commercial bought a new stake in shares of Amrize during the 2nd quarter valued at $109,000. TD Asset Management Inc bought a new stake in shares of Amrize during the 2nd quarter valued at $8,190,000. Finally, Allspring Global Investments Holdings LLC bought a new stake in shares of Amrize during the 2nd quarter valued at $62,646,000.

Insider Transactions at Amrize

In other news, insider Stephen S. Clark acquired 5,000 shares of the business's stock in a transaction dated Friday, August 15th. The stock was purchased at an average cost of $51.82 per share, for a total transaction of $259,100.00. Following the acquisition, the insider owned 5,000 shares of the company's stock, valued at $259,100. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jaime Hill acquired 4,000 shares of the business's stock in a transaction dated Friday, August 8th. The stock was purchased at an average price of $46.40 per share, with a total value of $185,600.00. Following the completion of the acquisition, the insider directly owned 9,601 shares in the company, valued at approximately $445,486.40. This represents a 71.42% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 1,124,000 shares of company stock worth $53,225,260.

Amrize Trading Down 1.0%

AMRZ opened at $48.53 on Thursday. The business has a 50-day moving average price of $50.58. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $56.29. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.38 and a quick ratio of 0.85.

Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.03 by ($0.25). The firm had revenue of $3.22 billion during the quarter.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AMRZ. JPMorgan Chase & Co. boosted their price objective on Amrize from $52.00 to $60.00 and gave the company an "overweight" rating in a research note on Tuesday, August 26th. Zacks Research upgraded Amrize from a "strong sell" rating to a "hold" rating in a research note on Friday, October 10th. UBS Group upped their target price on Amrize from $49.00 to $52.00 and gave the stock a "neutral" rating in a research note on Tuesday. Weiss Ratings restated a "hold (c-)" rating on shares of Amrize in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada decreased their target price on Amrize from $61.00 to $54.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $57.00.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.